Effect of haemolysis on the determination of CCL17/thymus and activation-regulated chemokine (TARC) and CCL22/macrophage-derived chemokine (MDC)

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Visual assessment of sample quality: quo usque tandem?
4. Reviews
5. Machine learning in laboratory medicine: waiting for the flood?
6. Is irisin the new player in exercise-induced adaptations or not? A 2017 update
7. Opinion Paper
8. Can a combination of average of normals and “real time” External Quality Assurance replace Internal Quality Control?
9. Genetics and Molecular Diagnostics
10. The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography
11. General Clinical Chemistry and Laboratory Medicine
12. Laboratory performance of sweat conductivity for the screening of cystic fibrosis
13. Making sense of a haemolysis monitoring and reporting system: a nationwide longitudinal multimethod study of 68 Australian laboratory participant organisations
14. Visual assessment of hemolysis affects patient safety
15. Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays
16. Validation of the Six Sigma Z-score for the quality assessment of clinical laboratory timeliness
17. Proficiency testing program for hemoglobin E, A₂ and F analysis in Thailand using lyophilized hemoglobin control materials
18. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm
19. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
20. An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer
21. Evaluation of the Aptima HBV Quant assay vs. the COBAS TaqMan HBV test using the high pure system for the quantitation of HBV DNA in plasma and serum samples
22. Reference Values and Biological Variations
23. Reference intervals for stone risk factors in 24-h urine among healthy adults of the Han population in China
24. Cardiovascular Diseases
25. Rule-out of non-ST elevation myocardial infarction by five point of care cardiac troponin assays according to the 0 h/3 h algorithm of the European Society of Cardiology
26. Infectious Diseases
27. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome
28. Association of adrenal hormone metabolites and mortality over a 6-year follow-up in COPD patients with acute exacerbation
29. Corrigendum
30. Corrigendum to: Validation of a pneumatic tube system to transport surgical pathology biopsy samples
31. Letters to the Editor
32. A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium
33. Detection and a functional characterization of the novel FBN1 intronic mutation underlying Marfan syndrome: case presentation
34. Effect of haemolysis on the determination of CCL17/thymus and activation-regulated chemokine (TARC) and CCL22/macrophage-derived chemokine (MDC)
35. Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry
36. Impact of citrated blood collection tubes on red cell morphology: implications for the measurement of plasma glucose
37. Validation of a pneumatic tube system to transport surgical pathology biopsy samples
38. Antioxidant capacity in patients with type 2 diabetes: a preliminary investigation on gender-specific differences in an Italian population